Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism

Journal of Neuroscience Research

Volumn 44, Issue 2, 1996, Pages 174-183

  Kosel S ^a   Lucking C B ^a   Egensperger, R ^a   Mehraein, P ^a   Graeber, M B ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

complex I; debrisoquine 4 hydroxylase; genetic heterogeneity; mitochondrial heteroplasmy; neurodegeneration

Indexed keywords

4 HYDROXYDEBRISOQUINE; GLUTAMINE TRANSFER RNA; MITOCHONDRIAL DNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BRAIN MITOCHONDRION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; MISSENSE MUTATION; PARKINSONISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CATTLE; CHICKENS; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; DNA, MITOCHONDRIAL; FEMALE; GENOTYPE; HUMANS; LEWY BODIES; MALE; MICE; MIDDLE AGED; MITOCHONDRIA; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; NADH DEHYDROGENASE; POINT MUTATION; POLYMERASE CHAIN REACTION; RATS; REFERENCE VALUES; RNA, TRANSFER, GLN; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; XENOPUS LAEVIS;

EID: 0029880474     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960415)44:2<174::AID-JNR10>3.0.CO;2-6     Document Type: Article

References (55)

1. Adams RD, Victor M (1993): "Principles of Neurology." New York: McGraw-Hill, pp 975-982.
2. Anderson S, Bankier AT, Barrell BG, de Bruijn MHL, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJH, Staden R, Young IG (1981): Sequence and organization of the human mitochondrial genome. Nature 290: 457-470.
3. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR (1992): Mutant debrisoquine hydroxilation genes in Parkinson's disease. Lancet 339:1017-1018.
4. Attardi G, Chomyn A, Doolittle RF, Mariottini P, Ragan CI (1986): Seven unidentified reading frames of human mitochondrial DNA encode subunits of the respiratory chain NADH dehydrogenase. Cold Spring Harbor Symp Quant Biol 51:103-114.
5. Bancher C, Braak H, Fischer P, Jellinger KA (1993): Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 162: 179-182.
6. Duvoisin RC (1986): Genetics of Parkinson's disease. In Yahr MD, Bergmann KJ (eds): "Advances in Neurology." New York: Raven Press, pp 307-312.
7. Duvoisin RC (1993): The genetics of Parkinson's disease: A review. In Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds): "Advances in Neurology." New York: Raven Press, pp 306-315.
8. Fearnley IM, Walker JE (1992): Conservation of sequences of subunits of mitochondrial complex I and their relationships with other proteins. Biochim Biophys Acta 1140:105-134.
9. Gasser T, Wszolek ZK, Trofarter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO (1994): Genetic linkage studies in autosomal dominant parkinsonism: Evaluation of seven candidate genes. Ann Neurol 36:387-396.
10. Gibb WRG, Lees AJ (1988): The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752.
11. Golbe LI, Lazzarini AM, Schwarz KO, Mark MH, Dickson DW, Duvoisin RC (1993): Autosomal dominant parkinsonism with benign course and typical Lewy-body pathology. Neurology 43:2222-2227.
12. Goodfellow PN, Schmitt K (1994): From the simple to the complex. Nature 371:105.
13. Gough AC. Miles JS, Spurr NK, Moss JE. Gaedigk A, Eichelbaum M, Wolf CR (1990): Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature 347:773-776.
14. Graeber MB, Kupke KG, Mueller U (1992): Delineation of the dystonia-parkinsonism syndrome locus in Xq13. Proc Natl Acad Sci USA 89:8245-8248.
15. Hattori N, Tanaka M, Ozawa T. Mizuno Y (1991): Immunohisto-chemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 30:563-571.
16. Heim MH. Meyer UA (1992): Evolution of highly polymorphic human cytochrome P450 gene cluster: CYP2D6. Genomics 14: 49-58.
17. Hotamisligil GS, Girmen AS, Fink JS, Tivol E, Shalish C, Trofatter J, Baenziger J. Diamond S, Markham C, Sullivan J, Growdon J, Breakefield XO (1994): Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Movement Disord 9:305-310.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992): Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184.
19. Hutchin T, Cortopassi G (1995): A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 92:6892-6895.
20. Janetzky B, Hauck S, Youdim MBH, Riederer P, Jellinger K, Pantucek F, Zöchling R, Boissl KW, Reichmann H (1994): Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci Lett 169:126-128.
21. Johnson WG (1991): Genetic susceptibility to Parkinson's disease. Geriatrics 46:52-95.
22. Johnson WG, Hodge SE, Duvoisin R (1990): Twin studies and the genetics of Parkinson's disease: A reappraisal. Movement Disord 5:187-194.
23. Jun AS, Brown MD, Wallace DC (1994): A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 91:6206-6210.
24. Kagimoto M, Heim M, Kagimoto K, Zeugin T, Meyer UA (1990): Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. J Biol Chem 265:17209-17214.
25. Kobayashi Y, Sharpe H, Brown N (1994): Single-cell analysis of intercellular heteroplasmy of mtDNA in Leber hereditary optic neuropathy. Am J Hum Genet 55:206-209.
26. Kondo I, Kanazawa I (1993): Debrisoquine hydroxylase and Parkinson's disease. In Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds): "Advances in Neurology." New York: Raven Press, pp 338-342.
27. Kösel S, Graeber MB (1993): Non-radioactive direct sequencing of PCR products amplified from neuropathological specimens. Brain Pathol 3:421-424.
28. Kösel S, Graeber MB (1994): Use of neuropathological tissue for molecular genetic studies: Parameters affecting DNA extraction and polymerase chain reaction. Acta Neuropathol (Berl) 88:19-25.
29. Kösel S, Egensperger R, Mehraein P, Graeber MB (1994): No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease. Biochem Biophys Res Commun 203:745-749.
30. 450 CYP2D6 allelic frequencies in Parkinson's disease. Am J Med Genet 48:166-168.
31. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD (1993): Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 33:368-372.
32. Landwehrmeyer GB, Mcneil SM, Dure LS, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E, Deyoung M, Avila-Gonzales AJ, Wexler NS, Difiglia M, Gusella JF, MacDonald ME, Penney JB, Young AB, Vonsattel JP (1995): Huntington's disease gene: Regional and cellular expression in brain of normal and affected individuals. Ann Neurol 37:218-230.
33. Langston JW, Ballard P, Tetrad JW, Irwin I (1983): Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
34. Lin FH, Lin R, Wisniewski HM, Hwang YW, Grundke-Iqbal I, Healy-Louie G, Iqbal K (1992): Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun 182:238-246.
35. Lücking CB, Kösel S, Mehraein P, Graber MB (1995): Absence of the mitochondrial A7237T mutation in Parkinson's disease. Biochem Biophys Res Commun 211:700-704.
36. Mackintosh NJ (1995): Insight into intelligence. Nature 377:581-582.
37. Leu[3243]) in tissues of symptomatic relatives with MELAS: The role of mitochondrial segregation. Neurology 43:1586-1590.
38. Mirra SS, Heyman A, McKeel D, Sumi SM, Grain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991): The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
39. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989): Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163:1450-1455.
40. Münscher C, Rieger T, Müller-Höcker J, Kadenbach B (1993): The point mutation of mitochondrial DNA characteristic for MERRF disease patients is found also in healthy people of different ages. FEBS Lett 317:27-30.
41. Ozawa T, Tanaka M, Ino H, Ohno K, Sano T, Wada Y, Yoneda M, Tanno Y, Miyatake T, Tanaka T, Itoyama S, Dcebe S, Hattori N, Mizuno Y (1991): Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem Biophys Res Commun 176:938-946.
42. Paterson AH, Lander ES, Hewitt JD, Peterson S, Lincoln SE, Tanksley SD (1988): Resolution of quantitative traits into Mendehan factors by using a complete linkage map of restriction fragment length polymorphisms. Nature 335:721-726.
43. Paterson AH, De Verna JW, Lanini B, Tanksley SD (1990): Fine mapping of quantitative trait loci using selected overlapping recombinant chromosomes, in an interspecies cross of tomato. Genetics 124:735-742.
44. Plomin R, Owen MJ, McGuffin P (1994): The genetic basis of complex human behaviors. Science 264:1733-1739.
45. Rajput AH, Rozdilsky B, Rajput A (1991): Accuracy of clinical diagnosis in parkinsonism-A prospective study. Can J Neurol Sci 18:275-278.
46. Ray-Chaudhuri K, Smith C, Gough AC, Novak N, Chamoun V, Wolf CR, Leigh PN (1995): Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 58:109.
47. Reusche E (1991): Silver staining of senile plaques and neurofibrillary tangles in paraffin sections-A simple and effective method. Pathol Res Pract 187:1045-1049.
48. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989): Mitochondrial complex I deficiency in Parkinson's disease. Lancet i:1269.
49. Schapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990): Anatomic and disease spec-ificity of NADH CoQl reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55:2142-2145.
50. lys mutation. Cell 61:931-937.
51. Shoffner IM, Brown MD, Torrini A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R, Watts RL, Juncos JL, Hansen LA, Crain BJ, Fayad M, Reckord CL, Wallace DC (1993): Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17:171-184.
52. Smith CAD, Gough AC, Leigh PN, Summers BA, Harding AE, Maranganore DM, Sturman SG, Schapira AHV, Williams AC, Spurr NK, Wolf CR (1992): Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkiason's disease. Lancet 339:1375-1377.
53. Tsuneoka Y, Matsuo Y, Iwahashi K, Takeuchi H, Ichikawa Y (1993): A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J Biochem (Tokyo) 114:263-266.
54. Wallace DC (1994): Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 91:8739-8746.
55. Wallace DC, Singh G, Lett MT, Hogde JA, Schurr TG, Lezza AMS, Elsas LJ, Nikoskelainen EK (1988): Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427-1430.